ABSTRACT
OBJECTIVES: Consanguinity is common in Tunisia. However, little information exists on its impact on recessive disorders. In this study, we evaluate the impact of consanguineous marriages on the occurrence of some specific autosomal recessive disorders and consider how other factors, such as population substructure and mutation frequency, may be of equal importance in disease prevalence. METHODS: Consanguinity profiles were retrospectively studied among 425 Tunisian patients suffering from autosomal recessive xeroderma pigmentosum, dystrophic epidermolysis bullosa, nonsyndromic retinitis pigmentosa, Gaucher disease, Fanconi anemia, glycogenosis type I, and ichthyosis, and compared to those of a healthy control sample. RESULTS: Consanguinity was observed in 341 cases (64.94%). Consanguinity rates per disease were 75.63, 63.64, 60.64, 61.29, 57.89, 73.33, and 51.28%, respectively. First-cousin marriages were the most common form of consanguinity (48.94%) with the percentages of 55.46, 45.46, 47.87, 48.39, 45.61, 56.66, and 35.90%, respectively. A very high level of geographic endogamy was also observed (93.92%), with the values by disease ranging between 75.86 and 96.64%. We observed an overall excess risk associated to consanguinity of nearly sevenfold which was proportional to the number of affected siblings and the frequency of disease allele in the family. Consanguinity was significantly associated with the first five cited diseases (odds ratio = 24.41, 15.17, 7.5, 5.53, and 5.07, respectively). However, no meaningful effects were reported among the remaining diseases. CONCLUSIONS: This study reveals a variation in the excess risk linked to consanguinity according to the type of disorder, suggesting the potential of cryptic population substructure to contribute to disease incidence in populations with complex social structure like Tunisia. It also emphasizes the role of other health and demographic aspects such as mutation frequency and reproductive replacement in diseases etiology.
Subject(s)
Gene Frequency , Genes, Recessive , Genetic Predisposition to Disease/genetics , Adolescent , Adult , Aged , Alleles , Child , Child, Preschool , Consanguinity , Female , Humans , Infant , Infant, Newborn , Male , Middle Aged , Prevalence , Tunisia/epidemiology , Young AdultABSTRACT
Located at the cross-road between Europe and Africa, Tunisia is a North African country of 11 million inhabitants. Throughout its history, it has been invaded by different ethnic groups. These historical events, and consanguinity, have impacted on the spectrum and frequency of genetic diseases in Tunisia. Investigations of Tunisian families have significantly contributed to elucidation of the genetic bases of rare disorders, providing an invaluable resource of cases due to particular familial structures (large family size, consanguinity and share of common ancestors). In the present study, we report on and review different aspects of consanguinity in the Tunisian population as a case study, representing several features common to neighboring or historically related countries in North Africa and the Middle East. Despite the educational, demographic and behavioral changes that have taken place during the last four decades, familial and geographical endogamy still exist at high frequencies, especially in rural areas. The health implications of consanguinity in Tunisian families include an increased risk of the expression of autosomal recessive diseases and particular phenotypic expressions. With new sequencing technologies, the investigation of consanguineous populations provides a unique opportunity to better evaluate the impact of consanguinity on the genome dynamic and on health, in addition to a better understanding of the genetic bases of diseases.
Subject(s)
Consanguinity , Genetic Diseases, Inborn/epidemiology , Genetics, Population , Genome, Human/genetics , Marriage/statistics & numerical data , Founder Effect , Genetic Diseases, Inborn/genetics , Humans , Tunisia/epidemiologyABSTRACT
Genetic deficiency of the glycogen debranching enzyme causes glycogen storage disease type III, an autosomal recessive inherited disorder. The gene encoding this enzyme is designated as AGL gene. The disease is characterized by fasting hypoglycemia, hepatomegaly, growth retardation, progressive myopathy and cardiomyopathy. In the present study, we present clinical features and molecular characterization of two consanguineous Tunisian siblings suffering from Glycogen storage disease type III. The full coding exons of the AGL gene and their corresponding exon-intron boundaries were amplified for the patients and their parents. Gene sequencing identified a novel single point mutation at the conserved polypyrimidine tract of intron 21 in a homozygous state (IVS21-8A>G). This variant cosegregated with the disease and was absent in 102 control chromosomes. In silico analysis using online resources showed a decreased score of the acceptor splice site of intron 21. RT-PCR analysis of the AGL splicing pattern revealed a 7 bp sequence insertion between exon 21 and exon 22 due to the creation of a new 3' splice site. The predicted mutant enzyme was truncated by the loss of 637 carboxyl-terminal amino acids as a result of premature termination. This novel mutation is the first mutation identified in the region of Bizerte and the tenth AGL mutation identified in Tunisia. Screening for this mutation can improve the genetic counseling and prenatal diagnosis of GSD III.
Subject(s)
Glycogen Debranching Enzyme System/genetics , Glycogen Storage Disease Type III/genetics , Introns , Point Mutation , Consanguinity , DNA Mutational Analysis , Female , Gene Order , Glycogen Storage Disease Type III/metabolism , Humans , Infant , Infant, Newborn , Male , RNA Splice Sites , Siblings , TunisiaSubject(s)
Gaucher Disease/diagnosis , Adult , Aged , Female , Humans , Male , Middle Aged , Splenomegaly/etiologyABSTRACT
Alternative medicine is more popular than ever before and Dermatology has not remained unaffected by this trend. The aim of this review was to summarise all surveys of dermatological patients regarding the usage of alternative medicine to assess the potential efficacy of alternative medicine and to understand the reasons for which patients use alternative therapies. Computarized literature search was performed in medline. The search terms were "alternative medicine", "skin" and the name of different alternative therapies. Numerous studies have been practiced and published but few randomised controlled trials have been carried out. Greater knowledge of alternative medicine and its philosophical background and practical uses should result in better care for our patients and stimulate clinical research that will allow further consideration of its appropriate use and better evaluation of its possible danger.
Subject(s)
Complementary Therapies , Skin Diseases/therapy , HumansSubject(s)
Gaucher Disease/epidemiology , Gaucher Disease/genetics , Glucosylceramidase/genetics , Mutation , Alleles , Female , Genotype , Humans , Male , Tunisia/epidemiologyABSTRACT
BACKGROUND: Distal renal tubular acidosis (dRTA) is a rare genetic disease caused by mutations in different genes involved in the secretion of H+ ions in the intercalated cells of the collecting duct. Both autosomal dominant and recessive forms have been described; the latter is also associated with sensorineural hearing loss. METHODS: Twenty-two Tunisian families were analyzed for mutations in the ATP6V1B1 and ATP6V0A4 genes by direct sequencing. Dating of the founder mutations was performed. RESULTS: Two founder mutations in the ATP6V1B1 gene were found in 16/27 dRTA cases. The p.Ile386Hisfs*56 founder mutation was estimated to be older than 2400 years and no correlations were found with deafness. For the remaining patients, two mutations in the ATP6V0A4 gene, one of them being novel, were found in three Tunisian cases. The presence of a heterozygous missense mutation p.T30I, of the ATP6V1B1 gene, was identified in six patients, while no mutations of the second gene were detected. No deleterious mutations of either ATP6V1B1 or ATP6V0A were found for the two probands. CONCLUSION: Our study gives evidence of phenotypic and genotypic heterogeneity of dRTA in the Tunisian population. Five different mutations were found, two of them were due to a founder effect, and screening of these mutations could provide a rapid and valuable tool for diagnosis of dRTA.
Subject(s)
Acidosis, Renal Tubular/genetics , Founder Effect , Mutation , Vacuolar Proton-Translocating ATPases/genetics , Case-Control Studies , Female , High-Throughput Nucleotide Sequencing , Humans , Male , TunisiaABSTRACT
BACKGROUND: Primary hyperoxaluria type 1 (PH1) is an autosomal recessive inherited metabolic disease, characterized by progressive kidney failure due to renal deposition of calcium oxalate. Mutations in the AGXT gene, encoding the liver-specific enzyme alanine glyoxylate aminotransferase, are responsible for the disease. We aimed to determine the mutational spectrum causing PH1 and to provide an accurate tool for diagnosis as well as for prenatal diagnosis in the affected families. METHODS: Direct sequencing was used to detect mutations in the AGXT gene in DNA samples from 13 patients belonging to 12 Tunisian families. RESULTS: Molecular analysis revealed five mutations causing PH1 in Tunisia. The mutations were identified along exons 1, 2, 4, 5 and 7. The most predominant mutations were the Maghrebian "p.I244T" and the Arabic "p.G190R". Furthermore, three other mutations characteristic of different ethnic groups were found in our study population. These results confirm the mutational heterogeneity related to PH1 in Tunisian population. All the mutations are in a homozygous state, reflecting the high impact of endogamy in our population. CONCLUSION: Mutation analysis through DNA sequencing can provide a useful first line investigation for PH1. This identification could provide an accurate tool for prenatal diagnosis, genetic counseling and screen for potential presymptomatic individuals.
Subject(s)
Hyperoxaluria, Primary/genetics , Mutation, Missense , Transaminases/genetics , Adolescent , Child , Child, Preschool , Consanguinity , DNA Mutational Analysis , Female , Genetic Association Studies , Haplotypes , Humans , Hyperoxaluria, Primary/diagnosis , Hyperoxaluria, Primary/enzymology , Infant , Male , Molecular Diagnostic Techniques , Polymorphism, Single Nucleotide , Tunisia , Young AdultABSTRACT
BACKGROUND: Gaucher disease (GD) is the most frequent lysosomal storage disorder; type 1 is by far the most common form. It is characterized by variability in age of onset, clinical signs and progression. It is usually diagnosed in the first or second decade of life with the appearance of bone pains, splenomegaly and thrombocytopenia, but the disease may be diagnosed at any age between 1 and 73 years. In the present study, we report 3 cases with late onset of GD in whom the disease was a surprise finding including one patient with Parkinson disease. This late onset is described as an adult form of Gaucher disease. FINDINGS: Molecular investigation showed mutational homogeneity in Tunisian adult patients suffering from GD. Indeed, all patients carry the p.N370S mutation: two patients at a homozygous state and one patient at compound heterozygous state. CONCLUSION: The p.N370S mutation presents a large variability in the onset of the disease and its clinical manifestation supporting the view that GD should be considered as a continuum phenotype rather than a predefined classification.
Subject(s)
Gaucher Disease/genetics , Glucosylceramidase/genetics , Mutation , Adult , Bone Diseases/genetics , Bone Marrow Examination , DNA Mutational Analysis , Female , Gaucher Disease/complications , Gaucher Disease/enzymology , Gaucher Disease/pathology , Gaucher Disease/therapy , Genetic Predisposition to Disease , Hepatomegaly/genetics , Heterozygote , Homozygote , Humans , Male , Middle Aged , Phenotype , Splenomegaly/genetics , Thrombocytopenia/genetics , TunisiaABSTRACT
Glycogen storage disease type III (GSD III) is an autosomal recessive disorder caused by the deficiency of glycogen debranching enzyme (AGL). It is characterized by hepatomegaly, progressive myopathy, cardiomyopathy and fasting hypoglycemia. Several mutations in AGL gene have been described in different populations. The W1327X mutation was reported in one Tunisian patient resident in Italy. We looked in this report to determine the frequency of W1327X mutation among Tunisian patients. The W1327X mutation was screening in 26 GSD III patients originated from various geographic locations in Tunisia. The sequence analysis revealed that among nine patients carried the W1327X mutation. Eight of them were from six unrelated families and they were originated from Mahdia (centre of Tunisia) suggesting the existence of a founder effect in this region. Taking into account historical migratory waves, screening for this mutation should be performed in priority for molecular diagnosis confirmation of GSD III in North African populations.